The popularity of copyright’s blockbuster initially sparked a period of growth for the drug industry, but recent shifts present a murky picture for investors. Off-patent competitors are eating into earnings, and https://idaombb870144.blog2news.com/41699452/the-blue-pill-and-pharma-a-risky-investment